Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PASCAL DABEL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1033306592
CMS profile
183447
Location
MISSION HILLS, CA

General Payments · PY2018–2024

$4,957.55

  • Reported across 241 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$832.62

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $832.62 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $322.85 16
Acerta Pharma LLC $169.60 8
GlaxoSmithKline, LLC. $131.25 4
Aurinia Pharma U.S., Inc. $108.41 4
NOVARTIS PHARMACEUTICALS CORPORATION $43.40 2
Lilly USA, LLC $32.20 1
CALLIDITAS THERAPEUTICS US INC. $24.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $937.34 52
PY2019 $847.59 39
PY2020 $319.54 16
PY2021 $366.01 15
PY2022 $773.90 39
PY2023 $880.55 44
PY2024 $832.62 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $32.30 02/07/2024 Food and Beverage Undisputed 01/23/2026 1117535246 CMS
Amgen Inc. $17.72 02/09/2024 Food and Beverage Undisputed 01/23/2026 1115546662 CMS
Amgen Inc. $17.49 03/06/2024 Food and Beverage Undisputed 01/23/2026 1115546671 CMS
Amgen Inc. $26.26 03/18/2024 Food and Beverage Undisputed 01/23/2026 1115546765 CMS
Amgen Inc. $23.03 04/10/2024 Food and Beverage Undisputed 01/23/2026 1115546775 CMS
Amgen Inc. $16.67 04/26/2024 Food and Beverage Undisputed 01/23/2026 1115546681 CMS
Amgen Inc. $23.45 05/15/2024 Food and Beverage Undisputed 01/23/2026 1115546694 CMS
Amgen Inc. $33.00 05/15/2024 Food and Beverage Undisputed 01/23/2026 1115546712 CMS
Amgen Inc. $30.64 05/22/2024 Food and Beverage Undisputed 01/23/2026 1115546781 CMS
Amgen Inc. $16.56 05/24/2024 Food and Beverage Undisputed 01/23/2026 1115546700 CMS
Amgen Inc. $13.58 07/29/2024 Food and Beverage Undisputed 01/23/2026 1115546719 CMS
Amgen Inc. $20.80 07/31/2024 Food and Beverage Undisputed 01/23/2026 1115546753 CMS
Amgen Inc. $2.43 07/31/2024 Food and Beverage Undisputed 01/23/2026 1115546757 CMS
Amgen Inc. $19.89 08/12/2024 Food and Beverage Undisputed 01/23/2026 1115546740 CMS
Amgen Inc. $6.67 08/16/2024 Food and Beverage Undisputed 01/23/2026 1115546730 CMS
Amgen Inc. $22.36 10/16/2024 Food and Beverage Undisputed 01/23/2026 1115546747 CMS
AstraZeneca Pharmaceuticals LP $21.16 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105415212 CMS
AstraZeneca Pharmaceuticals LP $22.22 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105841143 CMS
AstraZeneca Pharmaceuticals LP $24.68 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105443702 CMS
AstraZeneca Pharmaceuticals LP $22.27 06/19/2024 Food and Beverage Undisputed 01/23/2026 1104457046 CMS
AstraZeneca Pharmaceuticals LP $18.96 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104516076 CMS
AstraZeneca Pharmaceuticals LP $27.03 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104497816 CMS
AstraZeneca Pharmaceuticals LP $13.70 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105553612 CMS
AstraZeneca Pharmaceuticals LP $19.58 11/21/2024 Food and Beverage Undisputed 01/23/2026 1105284692 CMS
Aurinia Pharma U.S., Inc. $29.52 01/10/2024 Food and Beverage Undisputed 01/23/2026 1150678715 CMS
Aurinia Pharma U.S., Inc. $29.38 05/08/2024 Food and Beverage Undisputed 01/23/2026 1150678717 CMS
Aurinia Pharma U.S., Inc. $25.36 10/24/2024 Food and Beverage Undisputed 01/23/2026 1150678719 CMS
Aurinia Pharma U.S., Inc. $24.15 12/11/2024 Food and Beverage Undisputed 01/23/2026 1150678721 CMS
CALLIDITAS THERAPEUTICS US INC. $24.91 07/11/2024 Food and Beverage Undisputed 01/23/2026 1141518299 CMS
GlaxoSmithKline, LLC. $34.96 02/15/2024 Food and Beverage Undisputed 01/23/2026 1116395028 CMS
GlaxoSmithKline, LLC. $34.85 02/16/2024 Food and Beverage Undisputed 01/23/2026 1116449585 CMS
GlaxoSmithKline, LLC. $31.66 03/04/2024 Food and Beverage Undisputed 01/23/2026 1115841910 CMS
GlaxoSmithKline, LLC. $29.78 10/17/2024 Food and Beverage Undisputed 01/23/2026 1116022973 CMS
Lilly USA, LLC $32.20 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135306396 CMS
Novartis Pharmaceuticals Corporation $27.15 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086938063 CMS
Novartis Pharmaceuticals Corporation $16.25 12/10/2024 Food and Beverage Undisputed 01/23/2026 1086938071 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.